Validation of the portable Air-Smart Spirometer
- PMID: 29474502
- PMCID: PMC5825056
- DOI: 10.1371/journal.pone.0192789
Validation of the portable Air-Smart Spirometer
Abstract
Background: The Air-Smart Spirometer is the first portable device accepted by the European Community (EC) that performs spirometric measurements by a turbine mechanism and displays the results on a smartphone or a tablet.
Methods: In this multicenter, descriptive and cross-sectional prospective study carried out in 2 hospital centers, we compare FEV1, FVC, FEV1/FVC ratio measured with the Air Smart-Spirometer device and a conventional spirometer, and analyze the ability of this new portable device to detect obstructions. Patients were included for 2 consecutive months. We calculate sensitivity, specificity, positive and negative predictive value (PPV and NPV) and likelihood ratio (LR +, LR-) as well as the Kappa Index to evaluate the concordance between the two devices for the detection of obstruction. The agreement and relation between the values of FEV1 and FVC in absolute value and the FEV1/FVC ratio measured by both devices were analyzed by calculating the intraclass correlation coefficient (ICC) and the Pearson correlation coefficient (r) respectively.
Results: 200 patients (100 from each center) were included with a mean age of 57 (± 14) years, 110 were men (55%). Obstruction was detected by conventional spirometry in 73 patients (40.1%). Using a FEV1/FVC ratio smaller than 0.7 to detect obstruction with the Air Smart-Spirometer, the kappa index was 0.88, sensitivity (90.4%), specificity (97.2%), PPV (95.7%), NPV (93.7%), positive likelihood ratio (32.29), and negative likelihood ratio (0.10). The ICC and r between FEV1, FVC, and FEV1 / FVC ratio measured by the Air Smart Spirometer and the conventional spirometer were all higher than 0.94.
Conclusion: The Air-Smart Spirometer is a simple and very precise instrument for detecting obstructive airway diseases. It is easy to use, which could make it especially useful non-specialized care and in other areas.
Conflict of interest statement
Figures
Similar articles
-
The utility of hand-held mobile spirometer technology in a resource-constrained setting.S Afr Med J. 2019 Mar 29;109(4):219-222. doi: 10.7196/SAMJ.2019.v109i4.13845. S Afr Med J. 2019. PMID: 31084684
-
Reliability and usability of a portable spirometer compared to a laboratory spirometer.BMC Pulm Med. 2025 May 10;25(1):228. doi: 10.1186/s12890-025-03690-1. BMC Pulm Med. 2025. PMID: 40349062 Free PMC article. Clinical Trial.
-
Validity of a portable spirometer in the communities of China.BMC Pulm Med. 2022 Mar 5;22(1):80. doi: 10.1186/s12890-022-01872-9. BMC Pulm Med. 2022. PMID: 35248001 Free PMC article.
-
Comparison of a portable, pneumotach flow-sensor-based spirometer (Spirofy™) with the vitalograph alpha Touch™ spirometer in evaluating lung function in healthy individuals, asthmatics, and COPD patients-a randomized, crossover study.BMC Pulm Med. 2024 May 10;24(1):230. doi: 10.1186/s12890-024-02972-4. BMC Pulm Med. 2024. PMID: 38730359 Free PMC article. Clinical Trial.
-
Accuracy and repeatability of a pocket turbine spirometer: comparison with a rolling seal flow-volume spirometer.Clin Physiol. 1993 Jan;13(1):89-98. doi: 10.1111/j.1475-097x.1993.tb00320.x. Clin Physiol. 1993. PMID: 8435980
Cited by
-
Overview of lunar dust toxicity risk.NPJ Microgravity. 2022 Dec 2;8(1):55. doi: 10.1038/s41526-022-00244-1. NPJ Microgravity. 2022. PMID: 36460679 Free PMC article. Review.
-
Reference equations for evaluation of spirometry function tests in South Asia, and among South Asians living in other countries.Eur Respir J. 2022 Dec 1;60(6):2102962. doi: 10.1183/13993003.02962-2021. Print 2022 Dec. Eur Respir J. 2022. PMID: 35896203 Free PMC article.
-
Novel App-Based Portable Spirometer for the Early Detection of COPD.Diagnostics (Basel). 2021 Apr 27;11(5):785. doi: 10.3390/diagnostics11050785. Diagnostics (Basel). 2021. PMID: 33925463 Free PMC article.
-
Reliability of Portable Spirometry Performed in the Korea National Health and Nutrition Examination Survey Compared to Conventional Spirometry.Tuberc Respir Dis (Seoul). 2021 Oct;84(4):274-281. doi: 10.4046/trd.2021.0016. Epub 2021 Mar 24. Tuberc Respir Dis (Seoul). 2021. PMID: 33940672 Free PMC article.
-
A Review of Portable Electronic Spirometers: Implications for Asthma Self-Management.Curr Allergy Asthma Rep. 2018 Aug 25;18(10):53. doi: 10.1007/s11882-018-0809-3. Curr Allergy Asthma Rep. 2018. PMID: 30145683
References
-
- Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med.20171;195(5):557–582. doi: 10.1164/rccm.201701-0218PP - DOI - PubMed
-
- Becker AB, Abrams EM. Asthma guidelines: the Global Initiative for Asthma in relation to national guidelines. Curr Opin Allergy Clin Immunol.2017;17(2):99–103. doi: 10.1097/ACI.0000000000000346 - DOI - PubMed
-
- Represas-Represas C, Botana-Rial M, Leiro-Fernández V, González-Silva A., García-Martínez A, Fernández-Villar A. Short- and Long-Term Effectiveness of a Supervised Training Program in Spirometry Use for Primary Care Professionals. Arch Bronconeumol.2013;49:378–382. doi: 10.1016/j.arbres.2013.01.001 - DOI - PubMed
-
- De Miguel-Díez J, Izquierdo-Alonso J.L, Rodríguez-González-Moro J.M, Lucas-Ramos P.D, Bellón-Cano J.M, Molina-Paris J. Reliability of chronic obstructive pulmonary disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors. Arch Bronconeumol.2004;40:431–7. - PubMed
-
- Represas-Represas C, Botana-Rial M, Leiro-Fernández V, Gonzalez Silva A, Del Campo Pérez V, Fernández Villar A. Validación del dispositivo portátil COPD-6 para la detección de patologías obstructivas de la vía aérea. Arch Bronconeumol.2010;46:426–432. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources